RxDoctor Payments DataLook up a doctor →

Brendan Carry, MD

Advanced Heart Failure and Transplant Cardiology · Danville, PANPI 1376836395

Payments from drug & device makers

$692,522in general payments, 2019–2025

Across 394 payments — averaging $1757.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$235K
  • Alnylam Pharmaceuticals Inc.$165K
  • Pfizer$124K
  • Daxor Corporation$85K
  • Bridgebio Pharma, Inc.$29K
  • Astrazeneca UK Limited$22K
  • plus $32K from 9 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$692,522 in reported general payments places this provider in the 90th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.

See all advanced heart failure and transplant cardiology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$99,367
Medicare patients
1,494
Services billed
2,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Danville

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →